4//SEC Filing
INVESTOR GROWTH CAPITAL LTD 4
Accession 0001181431-09-057864
CIK 0001070336other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:17 PM ET
Size
13.6 KB
Accession
0001181431-09-057864
Insider Transaction Report
Form 4
INVESTOR AB
10% Owner
Transactions
- Sale
Common Stock
2009-12-16$3.35/sh−450,000$1,509,030→ 2,448,360 total(indirect: See Footnote) - Sale
Common Stock
2009-12-16$3.35/sh−315,000$1,056,321→ 1,713,862 total - Sale
Common Stock
2009-12-17$3.24/sh−124,700$404,589→ 2,323,660 total(indirect: See Footnote) - Sale
Common Stock
2009-12-17$3.24/sh−87,290$283,212→ 1,626,572 total
Footnotes (6)
- [F1]315,000 shares of Common Stock, par value $0.001 (the "Common Stock"), were sold by Investor Growth Capital Limited and 135,000 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities.
- [F2]These shares of Common Stock were sold by Investor Growth Capital Limited.
- [F3]87,290 shares of Common Stock were sold by Investor Growth Capital Limited and 37,410 shares of Common Stock were sold by Investor Group, L.P. The shares of Common Stock reported in Column 5 are held directly by Investor Growth Capital Limited and Investor Group, L.P. Investor Growth Capital Limited is an indirect wholly-owned subsidiary of Investor AB. Investor Group, L.P. is a limited partnership of which Investor AB is the indirect general partner. Investor AB may be deemed to beneficially own the securities held by Investor Growth Capital Limited and Investor Group, L.P. Investor AB disclaims beneficial ownership of such securities except to the extent of its pecuniary interest in such securities.
- [F4]These shares of Common Stock were sold by Investor Growth Capital Limited.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.16 to $3.745. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.0907 to $3.4035. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
ACHILLION PHARMACEUTICALS INC
CIK 0001070336
Entity typeother
Related Parties
1- filerCIK 0001237710
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 7:17 PM ET
- Size
- 13.6 KB